{"id":"NCT00358215","sponsor":"Amgen","briefTitle":"RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial","officialTitle":"A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06-01","primaryCompletion":"2012-10-11","completion":"2012-10-11","firstPosted":"2006-07-31","resultsPosted":"2013-12-13","lastUpdate":"2022-11-08"},"enrollment":2278,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure","Anemia","Cardiovascular Disease","Ventricular Dysfunction","Congestive Heart Failure"],"interventions":[{"type":"DRUG","name":"Darbepoetin alfa","otherNames":["Aranesp®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Darbepoetin alfa","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.","primaryOutcome":{"measure":"Time to All Cause Death or First Hospitalization for Worsening Heart Failure","timeFrame":"From randomization to the end of study; maximum time on study was 73 months","effectByArm":[{"arm":"Placebo","deltaMin":1260,"sd":null},{"arm":"Darbepoetin Alfa","deltaMin":1184,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.871"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":754,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","Czechia","Denmark","Estonia","Finland","France","Germany","Hong Kong","Hungary","India","Israel","Italy","Latvia","Lithuania","Mexico","Netherlands","Norway","Poland","Portugal","Puerto Rico","Romania","Russia","Slovakia","South Africa","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["19633103","23473338","36791280","30051179","29367268"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":741,"n":1140},"commonTop":["Dyspnoea","Diarrhoea","Dizziness","Cough","Oedema peripheral"]}}